BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsOpen-House Model for Non-Exclusive Discount Agreements on Brinzolamid/Brimonidin
    Open tender

    Open-House Model for Non-Exclusive Discount Agreements on Brinzolamid/Brimonidin

    Tender closes
    379d
    31 Oct 2027 · in 13 months

    This contract opportunity involves establishing non-exclusive discount agreements for pharmaceuticals containing the active ingredients Brinzolamid and Brimonidin (official ATC code: S01EC24) under the German Social Code. The agreements will be made through an Open-House model, allowing all interest

    🇩🇪GermanyPublished 24 Aug 2025· 1 years agoviaTED
    Tender closes
    379d
    31 Oct 2027 · in 13 months

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Tender closes
      31 Oct 2027
      379 days left
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Lifecycle

    Open

    379 days left to bid. Opened 1 years ago, deadline 31 Oct 2027.

    24 Aug 2025Today31 Oct 2027

    Brief

    This contract opportunity involves establishing non-exclusive discount agreements for pharmaceuticals containing the active ingredients Brinzolamid and Brimonidin (official ATC code: S01EC24) under the German Social Code. The agreements will be made through an Open-House model, allowing all interested pharmaceutical companies to participate during the application period, provided they meet the participation requirements. Individual contract negotiations will not take place, and exclusivity in supply is not guaranteed. The quantity of pharmaceuticals to be purchased is unknown and will depend on demand, the number of insured individuals, prescribing behavior of doctors, and the dispensing practices of public pharmacies. Minimum purchase quantities are not guaranteed. Interested pharmaceutical companies can download the participation documents from the German Procurement Portal (DTVP) after applying for access. Once access is granted, they can view the documents, which include the discount agreement and specified discounts, under strict confidentiality. Any sharing of these documents with third parties requires prior written consent from the contracting authority. If a company decides not to participate, all documents must be securely destroyed. Submission requirements are detailed in the documents "Cover Letter" and "Explanation of Contract Terms" available in the project room. Communication, including the submission of participation documents, will occur electronically via the DTVP portal. The first deadline for submission of participation applications is October 7, 2025, with further deadlines available in the project room. If a deadline falls on a weekend or public holiday, the next working day will be the new deadline. Late submissions will be considered at the next submission deadline. The discount agreement will end by October 31, 2027, regardless of the contract date. The contracting authority reserves the right to terminate the Open-House process early, especially if exclusive discount agreements are concluded, in which case existing agreements will end according to contractual terms. Based on past experiences, exclusive discount agreements typically take effect 8 to 12 months after the publication of the relevant contract notice in the EU Official Journal.

    More from AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA

    4 listingsView all →
    Healthcare & Medical🇩🇪Germany

    Open House Model for Fampridine Drug Discounts

    This contract opportunity involves establishing non-exclusive discount agreements for the drug Fampridine, as per German law. The agreements will be made available through an Open House model, allowing all interested pharmaceutical companies to participate if they meet the requirements. There will b

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 18 Dec 2025
    Healthcare & Medical🇩🇪Germany

    Non-Exclusive Discount Agreements for Beclometasone/Formoterol

    This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 17 Sept 2025
    ClosedHealthcare & Medical🇩🇪Germany

    Health Services Contract for Secondary Prevention Programs

    This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services in accordance with § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Healthy Back". The services will include conducting courses for patients at various locations in Saxony

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 28 Aug 2025
    ClosedHealthcare & Medical🇩🇪Germany

    Health Services Contract for Nutritional Counseling

    This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services as per § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Nutritional Counseling" under an "Open House Model". The services include individual consultations for patients at v

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 28 Aug 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Medical Countermeasures for Chemical, Biological, Radiological and Nuclear (CBRN) Threats - R&D Funding

    Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.

    est.£4,000,000
    Published 5 Nov 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Research Training Fellowship for Healthcare Professionals

    A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.

    Medical Research Council (MRC)
    Published 21 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Digital Mental Health Service for Children and Young People (South Staffordshire)

    Provide a digital mental health platform offering evidence-based therapeutic interventions and resources for children, young people, and families across South Staffordshire.

    MIDLANDS PARTNERSHIP FOUNDATION TRUST
    Published 18 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Digital Mental Health Service for Children and Young People in South Staffordshire

    Opportunity to provide a digital mental health platform delivering NICE-recommended therapeutic interventions and resources for children, young people, and families in South Staffordshire.

    MIDLANDS PARTNERSHIP FOUNDATION TRUST
    Published 16 Oct 2026
    Take action
    View tender on sourceTED

    Full notice and submission process on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    551011-2025

    Track

    Keep tabs on this tender

    Sonar emails you 7 and 2 days before it closes.

    Track this tender

    Free · No card

    Your fit

    Could you win this?

    A straight answer for your business — bid, partner or pass — based on who wins AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA's work like this.

    Check my fit

    Free · No card

    AP
    Buyer
    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Sector
    Healthcare & Medical